Versor Investments LP Invests $371,000 in CVS Health Co. (NYSE:CVS)

Versor Investments LP bought a new position in CVS Health Co. (NYSE:CVS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,900 shares of the pharmacy operator’s stock, valued at approximately $371,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CVS. Livelsberger Financial Advisory acquired a new stake in CVS Health in the third quarter worth $31,000. Reston Wealth Management LLC bought a new stake in CVS Health in the 3rd quarter valued at about $32,000. First Community Trust NA raised its holdings in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the last quarter. Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health in the 3rd quarter valued at approximately $33,000. Finally, ORG Partners LLC boosted its position in CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 592 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 3.4 %

CVS stock opened at $53.19 on Friday. The company’s 50 day simple moving average is $59.32 and its 200-day simple moving average is $58.76. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm has a market capitalization of $66.93 billion, a P/E ratio of 13.50, a P/E/G ratio of 0.93 and a beta of 0.55.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the prior year, the company earned $2.21 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.00%. CVS Health’s dividend payout ratio is 67.51%.

Analysts Set New Price Targets

CVS has been the topic of a number of recent analyst reports. Barclays cut their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. Truist Financial boosted their price target on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research report on Friday, October 11th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $72.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.